PT366 Drs. Rochelle & Dustin Hines Neurotransmitter Systems and Novel Psychedelic Molecules

Published: Oct. 21, 2022, 3:46 p.m.

b'

In this episode, Joe interviews Dr. Rochelle Hines, Ph.D. and Dr. Dustin Hines, Ph.D.: Co-Founders of Tesselate Therapeutics, which is focused on the development and testing of novel psychedelic molecules.\\xa0

www.psychedelicstoday.com

'